Italia markets closed

TEVA Jun 2024 22.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,95000,0000 (0,00%)
In data: 11:06AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente4,9500
ApertoN/D
Denaro4,3500
Domanda7,7500
Prezzo d'esercizio22,00
Scadenza2024-06-28
Min-Max giorno4,9500 - 4,9500
Contratto - Min-MaxN/D
VolumeN/D
Open Interest1
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.